ArticleAllergy2022
Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways.
Abstract readLetter
In one paragraph
Article in Allergy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Smoking and vaping alter genes related to mechanisms of SARS-CoV-2 susceptibility and severity: a systematic review and meta-analysis.The European respiratory journal · 2024Pooled it
- Expression of SARS-CoV-2 entry-associated proteins in COPD airways: an immunohistochemical study.The Journal of pathology · 2025Article
- scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome.Nature communications · 2025Article
- Spatiotemporal and demographic patterns of SARS-CoV-2 entry gene expression in a Lebanese cohort.Molecular biology reports · 2025Article
- The Association of Smoking and SARS-CoV-2 Infection.Tanaffos · 2024Article
- SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses.Clinical & translational immunology · 2024Article
- IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels.American journal of respiratory and critical care medicine · 2023Article
- Acute cigarette smoke exposure leads to higher viral infection in human bronchial epithelial cultures by altering interferon, glycolysis and GDF15-related pathways.Respiratory research · 2023Article
- Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium.Respiratory research · 2023Article
- Pan-Cancer Analysis of the COVID-19 Causal GeneACS omega · 2023Article
- Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD.Thorax · 2023Article
- Article
- Gene expression profiles in mesenchymal stromal cells from bone marrow, adipose tissue and lung tissue of COPD patients and controls.Respiratory research · 2023Article
- Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing.American journal of respiratory and critical care medicine · 2022Article
- Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease.Allergy · 2022Review
- Multiple relationships between aerosol and COVID-19: A framework for global studies.Gondwana research : international geoscience journal · 2021Article
Corrections and comments
- Update of
Authors and funding
37 authors.
Hananeh AlieeInstitute of Computational Biology, Helmholtz Centre, Munich, Germany.
Florian MassipBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Cancan QiUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.ORCID 0000-0003-3825-5802
Maria Stella de BiaseBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Jos van NijnattenUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
Elin T G KerstenUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
Nazanin Z KermaniDepartment of computing, Data Science Institute, Imperial College London, London, UK.
Basil KhuderDivision of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Judith M VonkUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
Roel C H VermeulenJulius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
U-BIOPRED study group
Cambridge Lung Cancer Early Detection Programme
INER-Ciencias Mexican Lung Program
Margaret NeighborsOMNI Biomarker Development, Genentech Inc., South San Francisco, California, USA.
Gaik W TewProduct Development Immunology, Infectious Disease & Opthalmology, Genentech Inc., South San Francisco, California, USA.
Michele A GrimbaldestonOMNI Biomarker Development, Genentech Inc., South San Francisco, California, USA.
Nick H T Ten HackenDepartment of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Sile HuDepartment of statistics, University of Oxford, Oxford, UK.
Yike GuoDepartment of computing, Data Science Institute, Imperial College London, London, UK.
Xiaoyu ZhangDepartment of computing, Data Science Institute, Imperial College London, London, UK.ORCID 0000-0002-6033-0525
Kai SunDepartment of computing, Data Science Institute, Imperial College London, London, UK.
Pieter S HiemstraDepartment of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
Bruce A PonderCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Mika J MäkeläDepartment of Allergy, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Kristiina MalmströmDepartment of Allergy, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Robert C RintoulDepartment of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK.
Paul A ReyfmanDivision of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0002-6435-6001
Fabian J TheisInstitute of Computational Biology, Helmholtz Centre, Munich, Germany.
Corry-Anke BrandsmaUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
Ian M AdcockNational Heart and Lung Institute, London, UK.
Wim TimensUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
Cheng-Jian XuResearch group Bioinformatics and Computational Genomics, Centre for Individualised Infection Medicine, CiiM, Hannover Medical School, Helmholtz Centre for Infection Research, Hannover, Germany.
Maarten van den BergeUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
Roland F SchwarzBerlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Gerard H KoppelmanUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
M C NawijnUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
Alen FaizUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands.
Funding
Single-Cell Transcriptomic Analysis to Identify Drivers of Pulmonary FibrosisK08HL146943 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI REYFMAN, PAUL A · 2020 to 2021
$326kATS Foundation/Boehringer Ingelheim Pharmaceuticals Inc. Research FellowshipCambridge BioresourceCambridge NIHR Biomedical Research CentreCancer Research UK Cambridge CentreChan Zuckerberg InitiativeChina Scholarship CouncilEuropean Union's H2020 Research and Innovation Program 874656European Union's Seventh Framework Programme FP7/2007-2013Helmholtz Association NIH K08HL146943Innovative Medicines Initiative Joint 115010Longfonds Junior FellowshipMedical Research Council MR/T010371/1NHLBI NIH HHS K08 HL146943Parker B. Francis FellowshipThe Netherlands Lung Foundation AF 4.1.14.001The Netherlands Ministry of Health, Welfare, and SportThe Netherlands Ministry of Spatial Planning, Housing, and the EnvironmentThe Netherlands Organization for Health Research and DevelopmentThe Netherlands Organization for Scientific Research
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19SARS-CoV-2HumansRespiratory SystemSerine EndopeptidasesSerine Endopeptidases
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.